Glycogen and Glycosylation: Friends or Foes? [PDF]
Konada RSR, Osborn J, Mitra S.
europepmc +1 more source
Inactivation of the Nrf2/Are pathway in AD leads to decreased antioxidant and anti‐inflammatory response and to the accumulation of beta‐amyloid (Aβ) plaques, resulting in cognitive failure. Treatment with Isoeugenol activates Nrf2, reversing these outcomes by promoting antioxidant response in neuronal cells (N2a) and by increasing the anti ...
Ana Silva +14 more
wiley +1 more source
Central nervous system histopathological findings in classic infantile Pompe disease: a systematic review with clinical relevance. [PDF]
van den Dorpel JJA +6 more
europepmc +1 more source
Health-Related Quality of Life in Pediatric Hepatic Glycogen Storage Disease: A Dual-Perspective Study. [PDF]
Aydin O +3 more
europepmc +1 more source
RNA sequencing resolves a novel noncanonical splice-region variant in <i>PHKA2</i> causing glycogen storage disease type IX α2: a case report. [PDF]
Chen F, He J, Cheng H, Shu S.
europepmc +1 more source
Lauric-acid-rich Hermetia illucens meal modulates lipid metabolism in the liver and the fatty acid profile in piglet tissues. [PDF]
Szczepanik K +3 more
europepmc +1 more source
Metabolic Myopathies and HyperCKemia in Adulthood: A Clinical Approach to Diagnosis and Management. [PDF]
Shakerdi LA.
europepmc +1 more source
Guidelines for home-based enzyme replacement therapy in children and adolescents with mucopolysaccharidosis: a scoping review. [PDF]
Oliveira VR +6 more
europepmc +1 more source
Metabolomic Insights into Lysosomal Storage Diseases: An Untargeted View. [PDF]
Di Carlo G +12 more
europepmc +1 more source
Shifting Towards Empagliflozin First-Line Therapy in Glycogen Storage Disease Type Ib: A Nationwide Real-World Study. [PDF]
Uçar SK +32 more
europepmc +1 more source

